Identifying biomarkers in wound fluid for diabetic foot ulcers
Diabetic Foot Ulcer Wound Fluid Biomarker
['FUNDING_OTHER'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-11309403
This study is looking at special substances in the fluid from diabetic foot ulcers to see if they can help doctors predict how well the wounds will heal, which could lead to better and more personalized treatments for people with these types of wounds.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11309403 on ClinicalTrials.gov |
What this research studies
This research investigates the use of biomarkers found in the wound fluid of diabetic foot ulcers (DFUs) to predict healing outcomes. By analyzing metabolites in the wound fluid, the study aims to identify specific indicators that can help healthcare providers determine the effectiveness of current treatments and make timely decisions about alternative therapies. The approach involves a metabolomics analysis of wound fluid samples from patients with chronic wounds, focusing on identifying a key parameter that correlates with healing success. This could lead to more personalized and effective treatment strategies for patients suffering from DFUs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who have been diagnosed with diabetic foot ulcers.
Not a fit: Patients with diabetic foot ulcers who are not able to provide wound fluid samples or those with other complicating health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for diabetic foot ulcers, potentially reducing the need for amputations and enhancing patient quality of life.
How similar studies have performed: Previous research has shown promise in using biomarkers for wound healing, suggesting that this approach could yield valuable insights, although this specific application is relatively novel.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROY, SASHWATI — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: ROY, SASHWATI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.